Bienvenue sur HématoStat.net. Nous sommes le : 8, September 2024
Réf :HematoStat.net ; 2 (3) : V43
The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cellymphoma
https://doi.org/10.1016/j.annonc.2021.12.002
View all posts
Save my name, email, and website in this browser for the next time I comment.
Δ